RecruitingNCT05189314

RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study

Clinical Outcomes and Quality of Life Measures After Surgical Resection and Radiofrequency Ablation of Benign Thyroid Nodules


Sponsor

Columbia University

Enrollment

100 participants

Start Date

Aug 30, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this observational research is to evaluate and compare clinical outcomes after treatment for symptomatic benign multinodular goiter (MNG) patients. This is a data collection study in which we ask participants to give access to information generated before and after treatment of their condition.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is tracking clinical outcomes and quality of life in patients who have their benign thyroid nodules treated with radiofrequency ablation (RFA) — a minimally invasive procedure that uses heat to shrink the nodule without surgery. **You may be eligible if...** - You are an adult (18 years or older) - You have a benign thyroid nodule being treated with radiofrequency ablation **You may NOT be eligible if...** - You have a cardiac arrhythmia (irregular heartbeat) - You are pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREThyroidectomy

Surgical Resection of thyroid nodules

DEVICERadiofrequency Ablation

Radiofrequency Ablation of thyroid nodules


Locations(1)

Columbia University

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05189314


Related Trials